HIV-associated sub-acute sclerosing panencephalitis - an emerging threat?

Int J STD AIDS. 2017 Aug;28(9):937-939. doi: 10.1177/0956462416687675. Epub 2017 Jan 11.

Abstract

Earlier age of measles virus infection predisposes to development of sub-acute sclerosing panencephalitis (SSPE) and this risk is heightened in HIV-infected children. We describe a HIV-infected young adult on antiretroviral therapy, presenting with a non-classical, fulminant form of SSPE to highlight the unpredictable nature of measles presentation. The recent spate of measles outbreaks due to virus introduction in populations with sub-optimal vaccine coverage or waning immunity and co-existing paediatric HIV cohorts is a cause for concern.

Keywords: Sub-acute sclerosing panencephalitis; fulminant sub-acute sclerosing panencephalitis; human immunodeficiency virus; rapid cognitive decline in HIV.

Publication types

  • Case Reports

MeSH terms

  • Anticonvulsants / therapeutic use
  • Clonazepam / therapeutic use
  • Electroencephalography
  • Fatal Outcome
  • Humans
  • Male
  • Measles / complications*
  • Measles Vaccine / administration & dosage
  • Measles virus / immunology
  • Measles virus / metabolism*
  • Subacute Sclerosing Panencephalitis / diagnosis*
  • Subacute Sclerosing Panencephalitis / drug therapy
  • Subacute Sclerosing Panencephalitis / pathology
  • Valproic Acid / therapeutic use
  • Young Adult

Substances

  • Anticonvulsants
  • Measles Vaccine
  • Clonazepam
  • Valproic Acid